Completeness of West Nile virus testing in patients with meningitis and encephalitis during an outbreak in Arizona, USA

Epidemiology and Infection

Volumn 140, Issue 9, 2012, Pages 1632-1636

  Weber, I B ^a   Lindsey, N P ^a   Bunko Patterson, A M ^b   Briggs, G ^c   Wadleigh, T J ^b   Sylvester, T L ^b   Levy, C ^d   Komatsu, K K ^d   Lehman, J A ^a   Fischer, M ^a   Staples, J E ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b Maricopa County Department of Public Health   (United States)

^c Pinal County Division of Public Health   (United States)

^d ARIZONA DEPARTMENT OF HEALTH SERVICES   (United States)

Author keywords

Encephalitis; meningitis; surveillance; West Nile virus

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ENCEPHALITIS; EPIDEMIC; FEMALE; FLAVIVIRUS INFECTION; HEALTH CARE FACILITY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENINGITIS; NONHUMAN; PARALYSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; UNITED STATES; WEAKNESS; WEST NILE FLAVIVIRUS; WEST NILE FLAVIVIRUS INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARIZONA; CITIES; DISEASE OUTBREAKS; ENCEPHALITIS, VIRAL; FEMALE; HUMANS; MALE; MENINGITIS, VIRAL; MIDDLE AGED; POPULATION SURVEILLANCE; WEST NILE FEVER; WEST NILE VIRUS;

EID: 84864495311     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268811002494     Document Type: Article

References (14)

1. Reimann CA, et al. Epidemiology of neuroinvasive arboviral disease in the United States, 1999-2007. American Journal of Tropical Medicine and Hygiene 2008; 79: 974-979.
2. Mostashari F, et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based sero-epidemiological survey. Lancet 2001; 358: 261-264.
3. Sejvar JJ, Marfin AA. Manifestations of West Nile neuroinvasive disease. Reviews in Medical Virology 2006; 16: 209-224. (Pubitemid 44140719)
4. Lindsey NP, et al. Surveillance for human West Nile virus disease-United States, 1999-2008. Morbidity and Mortality Weekly Report. Surveillance Summaries 2010; 59: 1-17.
5. Custer B, et al. The cost-effectiveness of screening the U.S. blood supply for West Nile virus. Annals of Internal Medicine 2005; 143: 486-492.
6. Boehmer TK, et al. Use of hospital discharge data to evaluate notifiable disease reporting to Colorado's Electronic Disease Reporting System. Public Health Reports 2011; 126: 100-106.
7. Silk BJ, et al. Differential West Nile fever ascertainment in the United States: a multilevel analysis. American Journal of Tropical Medicine and Hygiene 2010; 83: 795-802.
8. Patnaik JL, Harmon H, Vogt RL. Follow-up of 2003 human West Nile virus infections, Denver, Colorado. Emerging Infectious Diseases 2006; 12: 1129-1131. (Pubitemid 44061285)
9. Lindsey NP, et al. West Nile virus disease in children, United States, 1999-2007. Pediatrics 2009; 123: e1084-1089.
10. Jean CM, et al. Risk factors for West Nile virus neuro-invasive disease, California, 2005. Emerging Infectious Diseases 2007; 13: 1918-1920. (Pubitemid 350248498)
11. Sejvar JJ. The long-term outcomes of human West Nile virus infection. Clinical Infectious Diseases 2007; 44: 1617-1624. (Pubitemid 46871510)
12. Unlu I, et al. Evaluation of surveillance methods for detection of West Nile virus activity in East Baton Rouge Parish, Louisiana, 2004-2006. Journal of the American Mosquito Control Association 2009; 25: 126-133.
13. Stramer SL, et al. Strategies for testing blood donors for West Nile virus. Transfusion 2006; 46: 2036-2037. (Pubitemid 44813719)
14. Centers for Disease Control and Prevention. Epidemic/epizootic West Nile virus in the United States: guidelines for surveillance, prevention, and control. Atlanta: CDC, 2003.